Lisa D Yee
City of Hope Medical Center · Ohio State University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Lisa D Yee as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:56 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06538389 · High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast CancerCity of Hope Medical Center · suspended · Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 · principal investigator
- N/ANCT04913064 · Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast CancerCity of Hope Medical Center · recruiting · Breast Carcinoma · principal investigator
- N/ANCT03865992 · Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint DiseaseCity of Hope Medical Center · active not recruiting · Breast Cancer, Joint Pain · principal investigator
- N/ANCT02295059 · Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer PreventionCity of Hope Medical Center · active not recruiting · Breast Cancer · principal investigator
- Ph1NCT01282580 · Dietary Fish and Omega 3 Fatty Acids for Breast Cancer PreventionOhio State University Comprehensive Cancer Center · completed · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Combined breast MRI/biomarker strategies to identify aggressive biologyU01CA189283 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2015 to 2020 · $649,862 awarded in 2020Same name and institution; not confirmed by an ID
- Omega-3 fatty acids and ERPR(-) and HER-2/neu(+) breast cancer preventionR01CA164019 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2014 to 2018 · $146,146 awarded in 2018Grant number is on one of their registry trials
- OMEGA 3 FATTY ACIDS SUPPLEMENTS IN WOMEN AT HIGH RISK FOR BREAST CANCERM01RR000034 · NCRR · OHIO STATE UNIVERSITY · fiscal years 2007 to 2008 · $5,890 awarded in 2008Same name and institution; not confirmed by an ID
- HER2/neu and dietary fat: interactions in breast cancerR21CA116024 · NCI · OHIO STATE UNIVERSITY · fiscal years 2005 to 2006 · $156,936 awarded in 2006Same name and institution; not confirmed by an ID
- FATTY ACIDS AND PPARS IN BREAST CANCER PREVENTIONK07CA086020 · NCI · OHIO STATE UNIVERSITY · fiscal years 2000 to 2005 · $66,325 awarded in 2005Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Leadership, Planning and EvaluationP30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2008 to 2026Named on NCT06538389, NCT04913064
- Alliance NCORP Research BaseUG1CA189823 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis, Olwen Hahn, ELECTRA D. PASKETT · fiscal years 2014 to 2026Named on NCT03865992
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 10:56 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer.Am J Surg · 199996 citationsRCR 4.1
- Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.Am J Clin Nutr · 201081 citationsRCR 2.3
- Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer.Ann Surg Oncol · 200652 citationsRCR 1.9
- Incorporation of eicosapentaenioic and docosahexaenoic acids into breast adipose tissue of women at high risk of breast cancer: a randomized clinical trial of dietary fish and n-3 fatty acid capsules.Mol Nutr Food Res · 201528 citationsRCR 1.3
- A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance).Cancer · 202125 citationsRCR 2.2
- Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer.Cancer Prev Res (Phila) · 202018 citationsRCR 1.0
- 15 citationsRCR 1.1
- Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial.Breast Cancer Res Treat · 202410 citationsRCR 2.3
- Randomized dose-response trial of n-3 fatty acids in hormone receptor negative breast cancer survivors - impact on breast adipose oxylipin and DNA methylation patterns.Am J Clin Nutr · 20255 citationsRCR 1.2
- Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904).BMC Med Inform Decis Mak · 20242 citationsRCR 0.2